Sang Geon Kim
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 33
- Drug-Induced Hepatotoxicity and Protection 20
- Molecular Biology top 1%
- Genomics, phytochemicals, and oxidative stress 64
- Glutathione Transferases and Polymorphisms 36
- Cancer Research top 1%
- Biochemistry top 0.5%
- Hepatology top 1%
- Liver physiology and pathology 16
-
- Liver Disease Diagnosis and Treatment 23
-
- Drug Transport and Resistance Mechanisms 17
-
- Endoplasmic Reticulum Stress and Disease 15
Sang Geon Kim
237 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Pharmacology 1.5k
- Molecular Biology 5.4k
- Cancer Research 1.1k
- Biochemistry 549
- Hepatology 578
Countries citing papers authored by Sang Geon Kim
This map shows the geographic impact of Sang Geon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sang Geon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sang Geon Kim more than expected).
Fields of papers citing papers by Sang Geon Kim
This network shows the impact of papers produced by Sang Geon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sang Geon Kim. The network helps show where Sang Geon Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sang Geon Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 3 | |
| 7 | 2020 | 35 | |
| 8 | 2018 | 43 | |
| 9 | 2017 | 14 | |
| 10 | 2012 | 76 | |
| 11 | 2011 | 33 | |
| 12 | 2011 | 12 | |
| 13 | 2009 | 182 | |
| 14 | 2006 | 95 | |
| 15 | 2004 | 12 | |
| 16 | 2002 | 23 | |
| 17 | 2001 | 42 | |
| 18 | 2001 | 30 | |
| 19 | 2000 | 17 | |
| 20 | Anti-tumor effect of the complex of acriflavine and guanosine(AG60) | 1997 | 0 |
About Sang Geon Kim
Sang Geon Kim is a scholar working on Pharmacology, Biochemistry and Hepatology, having authored 241 papers that have together received 9.4k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (64 papers), Glutathione Transferases and Polymorphisms (36 papers), Pharmacogenetics and Drug Metabolism (33 papers), Liver Disease Diagnosis and Treatment (23 papers), Drug-Induced Hepatotoxicity and Protection (20 papers), Drug Transport and Resistance Mechanisms (17 papers), Liver physiology and pathology (16 papers) and Endoplasmic Reticulum Stress and Disease (15 papers). The work is most often cited by research in Pharmacology (1.5k citations), Molecular Biology (5.4k citations) and Cancer Research (1.1k citations). Sang Geon Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Il Je Cho, Keon Wook Kang, Keon Wook Kang, Ja Hyun Koo, Seung Jin Lee, Tae Hyun Kim, Min Kyung Cho, Sung Hwan Ki, Sang Mi Shin and Chang Ho Lee. Their work appears in journals such as Molecular Pharmacology, Biochemical Pharmacology, Archives of Pharmacal Research, Chemico-Biological Interactions and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.